Sargent Bickham Lagudis’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-2,444
| Closed | -$152K | – | 782 |
|
2019
Q2 | $152K | Hold |
2,444
| – | – | 0.02% | 229 |
|
2019
Q1 | $152K | Hold |
2,444
| – | – | 0.02% | 240 |
|
2018
Q4 | $152K | Hold |
2,444
| – | – | 0.02% | 228 |
|
2018
Q3 | $152K | Hold |
2,444
| – | – | 0.02% | 233 |
|
2018
Q2 | $152K | Hold |
2,444
| – | – | 0.02% | 231 |
|
2018
Q1 | $152K | Hold |
2,444
| – | – | 0.02% | 239 |
|
2017
Q4 | $152K | Hold |
2,444
| – | – | 0.02% | 242 |
|
2017
Q3 | $152K | Hold |
2,444
| – | – | 0.02% | 241 |
|
2017
Q2 | $152K | Hold |
2,444
| – | – | 0.02% | 231 |
|
2017
Q1 | $152K | Hold |
2,444
| – | – | 0.02% | 236 |
|
2016
Q4 | $152K | Hold |
2,444
| – | – | 0.02% | 227 |
|
2016
Q3 | $152 | Hold |
2,444
| – | – | 0.02% | 232 |
|
2016
Q2 | $152K | Hold |
2,444
| – | – | 0.02% | 234 |
|
2016
Q1 | $152K | Buy |
+2,444
| New | +$152K | 0.02% | 235 |
|